toxo_gandhii Profile Banner
Ravi Gandhi 🦠 Profile
Ravi Gandhi 🦠

@toxo_gandhii

Followers
54
Following
22
Media
1
Statuses
12

Houston, TX
Joined November 2020
Don't wanna be here? Send us removal request.
@CIDJournal
Clinical Infectious Diseases
1 year
Amoxicillin-clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute βœ… Just Accepted πŸ”— https://t.co/hrlWLvVtlN
Tweet media one
0
27
51
@TheLancetInfDis
The Lancet Infectious Diseases
2 years
New research: Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial https://t.co/SxV3rFATlv
1
47
106
@SIDPharm
SIDP
3 years
We love a stoplight table! Check out this great summary made by @moore_wjustin of PsA resistance 🦠 to beta-lactams from the recent #Breakpoints discussion with @erinmccreary, @MaggieMonogue, and @aoliverp73. Then listen to the episode for all the details: https://t.co/ez0n3ae0fR
Tweet media one
6
187
506
@toxo_gandhii
Ravi Gandhi 🦠
3 years
Will be forever thankful for the opportunity to have trained with and to have learned from the best πŸ™πŸ½@WiscIDRx @uw_infdisease
@WiscIDRx
Wisconsin ID/Antimicrobial Stewardship
3 years
Congratulations πŸŽ‰ @CourtneyBaus & @toxo_gandhii for completing their PGY2 ID residency @UWHealth! Thank you for your hard work & dedication. We wish them all the best and look forward to watch them serve as ID experts in their new roles: Courtney: @UWHealth Ravi: @SAHealth210
Tweet media one
0
1
11
@WiscIDRx
Wisconsin ID/Antimicrobial Stewardship
4 years
Great article highlighting the recent work of our own @LucasTSchulz! Always looking for opportunities to improve abx use here @UWHealth. #twitterrx Reduce and Reuse: A Recipe to Beat Resistance
Tweet card summary image
pharmacy.wisc.edu
School of Pharmacy alum Lucas Schulz improves antibiotic usage and prescribing at UW Health to tackle antimicrobial resistance.
0
9
16
@TheLancet
The Lancet
4 years
In patients with community-acquired #pneumonia who meet clinical stability criteria, Ξ²-lactam treatment could be safely discontinued after 3 days, suggests findings from a new trial. This may enable a reduction in antibiotic consumption and resistance. https://t.co/sBVa3C8m6E
Tweet media one
2
62
124
@WiscIDRx
Wisconsin ID/Antimicrobial Stewardship
4 years
πŸ₯³We are excited to announce our PGY2 ID residents for 2021-2022, both @UTexasPharmacy grads: -@CourtneyBaus: PGY1 @UWHealth and staying on with us for PGY2 -Ravi Gandhi: PGY1 @SinaiChicago and matched with us for PGY2 🌟 Welcome Courtney and Ravi! 🌟@uw_infdisease
Tweet media one
Tweet media two
2
5
48
@toxo_gandhii
Ravi Gandhi 🦠
4 years
Blessed to continue my training in Madison πŸ™πŸ½ #TwitteRx
Tweet media one
2
0
32
@NEJM
NEJM
5 years
Safety and Efficacy of the BNT162b2 COVID-19 VaccineΒ  #COVID19 #IDTwitter
10
438
876
@BradSpellberg
Brad Spellberg
5 years
Alright ID Tweeps, Shorter Is Better table is now updated with new DFO study. Table is getting awfully full! https://t.co/1oaAT6koX3
Tweet media one
6
130
404
@IDdocAdi
Adi
5 years
Discontinuing antibiotics
@SportsCenter
SportsCenter
5 years
What's something that ISN'T a sport, but still FEELS like a sport?
11
30
271